These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome. Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047 [TBL] [Abstract][Full Text] [Related]
9. MECP2 isoform-specific vectors with regulated expression for Rett syndrome gene therapy. Rastegar M; Hotta A; Pasceri P; Makarem M; Cheung AY; Elliott S; Park KJ; Adachi M; Jones FS; Clarke ID; Dirks P; Ellis J PLoS One; 2009 Aug; 4(8):e6810. PubMed ID: 19710912 [TBL] [Abstract][Full Text] [Related]
10. Selective preservation of MeCP2 in catecholaminergic cells is sufficient to improve the behavioral phenotype of male and female Mecp2-deficient mice. Lang M; Wither RG; Brotchie JM; Wu C; Zhang L; Eubanks JH Hum Mol Genet; 2013 Jan; 22(2):358-71. PubMed ID: 23077217 [TBL] [Abstract][Full Text] [Related]
11. MeCP2 and Rett syndrome: reversibility and potential avenues for therapy. Gadalla KK; Bailey ME; Cobb SR Biochem J; 2011 Oct; 439(1):1-14. PubMed ID: 21916843 [TBL] [Abstract][Full Text] [Related]
12. MeCP2+/- mouse model of RTT reproduces auditory phenotypes associated with Rett syndrome and replicate select EEG endophenotypes of autism spectrum disorder. Liao W; Gandal MJ; Ehrlichman RS; Siegel SJ; Carlson GC Neurobiol Dis; 2012 Apr; 46(1):88-92. PubMed ID: 22249109 [TBL] [Abstract][Full Text] [Related]
13. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains. Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996 [TBL] [Abstract][Full Text] [Related]
14. Separate respiratory phenotypes in methyl-CpG-binding protein 2 (Mecp2) deficient mice. Bissonnette JM; Knopp SJ Pediatr Res; 2006 Apr; 59(4 Pt 1):513-8. PubMed ID: 16549521 [TBL] [Abstract][Full Text] [Related]
16. Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome. Ogier M; Wang H; Hong E; Wang Q; Greenberg ME; Katz DM J Neurosci; 2007 Oct; 27(40):10912-7. PubMed ID: 17913925 [TBL] [Abstract][Full Text] [Related]
17. The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression. Chang Q; Khare G; Dani V; Nelson S; Jaenisch R Neuron; 2006 Feb; 49(3):341-8. PubMed ID: 16446138 [TBL] [Abstract][Full Text] [Related]
18. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice. Deng V; Matagne V; Banine F; Frerking M; Ohliger P; Budden S; Pevsner J; Dissen GA; Sherman LS; Ojeda SR Hum Mol Genet; 2007 Mar; 16(6):640-50. PubMed ID: 17309881 [TBL] [Abstract][Full Text] [Related]
19. Novel MECP2 gene therapy is effective in a multicenter study using two mouse models of Rett syndrome and is safe in non-human primates. Powers S; Likhite S; Gadalla KK; Miranda CJ; Huffenberger AJ; Dennys C; Foust KD; Morales P; Pierson CR; Rinaldi F; Perry S; Bolon B; Wein N; Cobb S; Kaspar BK; Meyer KC Mol Ther; 2023 Sep; 31(9):2767-2782. PubMed ID: 37481701 [TBL] [Abstract][Full Text] [Related]